Trial Profile
Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs ORL-1G (Primary)
- Indications Glycogen storage disease XIV
- Focus Therapeutic Use
- Sponsors Orpha Labs
- 25 Jan 2018 New trial record